Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging: Evaluation of Analytical Methods
Open Access
- 1 November 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (21) , 10104-10112
- https://doi.org/10.1158/0008-5472.can-04-4297
Abstract
There is an unmet need to develop imaging methods for the early and objective assessment of breast tumors to therapy. 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT)–positron emission tomography represents a new approach to imaging thymidine kinase activity, and hence, cellular proliferation. We compared graphical, spectral, and semiquantitative analytic methodologies for quantifying [18F]FLT kinetics in tumor and normal tissue of patients with locally advanced and metastatic breast cancer. The resultant kinetic parameters were correlated with the Ki-67 labeling index from tumor biopsies. [18F]FLT accumulation was detected in primary tumor, nodal disease, and lung metastasis. In large tumors, there was substantial heterogeneity in regional radiotracer uptake, reflecting heterogeneity in cellular proliferation; radiotracer uptake in primary tumors also differed from that of metastases. [18F]FLT was metabolized in patients to a single metabolite [18F]FLT-glucuronide. Unmetabolized [18F]FLT accounted for 71.54 ± 1.50% of plasma radioactivity by 90 minutes. The rate constant for the metabolite-corrected net irreversible uptake of [18F]FLT (Ki) ranged from 0.6 to 10.4 × 10−4 and from 0 to 0.6 × 10−4 mL plasma cleared/s/mL tissue in tumor (29 regions, 15 patients) and normal tissues, respectively. Tumor Ki and fractional retention of radiotracer determined by spectral analysis correlated with Ki-67 labeling index (r = 0.92, P < 0.0001 and r = 0.92, P < 0.0001, respectively). These correlations were superior to those determined by semiquantitative methods. We conclude that [18F]FLT-positron emission tomography is a promising clinical tool for imaging cellular proliferation in breast cancer, and is most predictive when analyzed by graphical and spectral methods.Keywords
This publication has 31 references indexed in Scilit:
- Early Detection of Tumor Response to Chemotherapy by 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor Model In vivoCancer Research, 2005
- Prognostic value of proliferation in invasive breast cancer: a reviewJournal of Clinical Pathology, 2004
- Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapyEuropean Journal Of Cancer, 2004
- Kinetics of 3′-Deoxy-3′-[F-18]Fluorothymidine Uptake and Retention in DogsMolecular Imaging & Biology, 2002
- Investigations into the regioselective deuteriation of enolates derived from silyl enol ethers and enolacetatesJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- An improved synthesis of 3′‐DEOXY‐3′‐[18F]fluorothymidine ([18F]FLT) and the fate of the precursor, 2, 3′‐anhydro‐5′‐O‐(4, 4′‐dimethoxytrityl)‐thymidineJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- Spectral Analysis of Dynamic PET StudiesJournal of Cerebral Blood Flow & Metabolism, 1993
- Errors Introduced by Tissue Heterogeneity in Estimation of Local Cerebral Glucose Utilization with Current Kinetic Models of the [18F]Fluorodeoxyglucose MethodJournal of Cerebral Blood Flow & Metabolism, 1992
- The Influence of Tissue Heterogeneity on Results of Fitting Nonlinear Model Equations to Regional Tracer Uptake Curves: With an Application to Compartmental Models Used in Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1987
- Expression of thymidine kinase variants is a function of the replicative state of cellsCell, 1974